Complete response to avelumab and IL-15 superagonist N-803 with Abraxane in Merkel cell carcinoma: a case study Oct 4, 2020 | Merkel Cell Carcinoma
Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors Nov 5, 2018 | Uncategorized
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial Apr 5, 2018 | Uncategorized
The human IL-15 superagonist ALT-803 directs SIV-specific CD8(+) T cells into B-cell follicles. Feb 12, 2018 | Uncategorized
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation. Feb 12, 2018 | Uncategorized
